Purchase Order 80NSSC24PB470

Award Date 8/7/24
Potential Completion Date 2/6/25
Potential Value $148K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Birmingham, AL 35203, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
500
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
This is a $156,494 firm fixed price purchase order contract awarded by the NASA Shared Services Center, a civilian federal agency, to Encapsulate Inc., a self-certified small disadvantaged business. The contract is for Encapsulate Inc.'s FY24 SBIR (Small Business Innovation Research) Phase I project titled "NVASIVE: Unraveling the Enigma of Metastasis." The contract has a total small business set-aside designation and is scheduled for completion by February 6, 2025. This award supports...
This is a $249,938.08 firm fixed-price purchase order awarded to Physical Sciences Inc., a for-profit small business based in Andover, Massachusetts. The contract is for a Defense Health Agency (DHA) Small Business Innovation Research (SBIR) Phase I project titled "Degradable Polymer Nanoparticles for Controlled Drug Delivery in Treating Traumatic Brain Injury." The work will be performed in Andover, MA and the period of performance ends on September 2, 2025. This SBIR Phase I contract...
<p>This is a $299,813 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Hylapharm LLC, a self-certified small disadvantaged business, under the SBIR Program Phase I. The contract is for the development of &quot;Targeted Nanoparticle Treatment for Breast Cancer Stem Cells.&quot; This contract has a Total Small Business set-aside designation. The contract has an ultimate completion date of September 17, 2016.</p>
This is a $289,828.00 SBIR Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Nicolalde R&amp;D LLC, a minority-owned, self-certified small disadvantaged business. The contract is a firm fixed-price definitive contract with a completion date of November 30, 2021. The SBIR (Small Business Innovation Research) Program Phase I award indicates this contract is for early-stage research and development activities. As a...
This is a $249,988.57 firm fixed-price Phase I SBIR contract awarded by the Defense Health Agency (DHA) to TDA Research, Inc., a small business based in Colorado. The contract is for the development of a psoralen-UV-A inactivation-based high-throughput pathogen inactivation device. This SBIR contract supports research and development of an innovative medical device technology. TDA Research is an experienced government contractor, holding multiple SBIR and STTR awards as well as other federal...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Targagenix, Inc. for R&amp;D on a nanoemulsion formulation and IND-enabling studies of a novel cancer stem cell cytotoxic agent. The definitive, firm-fixed-price contract has a ceiling value of $2,284,577.00 and a period of performance ending on October 15, 2018. As an SBIR Phase I award, this contract supports early-stage research and development...
<p>This is a $1,999,386.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Avoneaux Medical Institute, LLC, a veteran-owned limited liability company. The contract is for the development of spatial micropurification technology under SBIR Topic 403. The contract is a definitive, firm fixed-price contract with a period of performance ending on September 18, 2024.</p>
<p>This is a $155,536.00 firm-fixed-price purchase order awarded by the Shared Services Center (part of a civilian agency) to Mizar Therapeutics Inc., a small business, under the SBIR Phase I program. The contract is for the FY24 SBIR Phase I - Mizar S/TAR High-Throughput Platform for Identification of Senescence Altering Therapeutics project, with a period of performance ending on February 6, 2025. The contract has a total small business set-aside designation.</p>
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled &quot;Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population.&quot; The contract has a period of performance from September 16,...

This is a $148,432 firm fixed-price SBIR Phase I contract awarded by the Shared Services Center of the Civilian Federal Agency to Truspin Nanomaterial Innovation, Inc., a self-certified small disadvantaged business. The contract is for the in-space production of dacarbazine-loaded nanofibers for cancer treatment. The work will be performed in Birmingham, AL and has a completion date of February 6, 2025. This SBIR Phase I contract is part of the agency's research and development program aimed at advancing innovative technologies.

Generated 7/27/24, 9:33 AM